These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 2676148

  • 1. Analysis of gp74 expression by transformed rat fibroblasts from experimental pulmonary metastases following specific ricin A-chain immunotoxin therapy.
    Roth JA, Thomsen S, Fry KD, Scannon P, Chang C.
    Cancer Res; 1989 Oct 15; 49(20):5708-12. PubMed ID: 2676148
    [Abstract] [Full Text] [Related]

  • 2. Mediation of reduction of spontaneous and experimental pulmonary metastases by ricin A-chain immunotoxin 45-2D9-RTA with potentiation by systemic monensin in mice.
    Roth JA, Ames RS, Fry K, Lee HM, Scannon PJ.
    Cancer Res; 1988 Jun 15; 48(12):3496-501. PubMed ID: 3259469
    [Abstract] [Full Text] [Related]

  • 3. Monoclonal antibody 45-2D9 conjugated to the A chain of ricin is specifically toxic to c-Ha-ras-transfected NIH 3T3 cells expressing gp74.
    Roth JA, Ames RS, Byers V, Lee HM, Scannon PJ.
    J Immunol; 1986 Mar 15; 136(6):2305-10. PubMed ID: 3950414
    [Abstract] [Full Text] [Related]

  • 4. Analysis of expression of cell surface antigen Mr 74,000 phosphoglycoprotein in normal, oncogene-transformed, and neoplastic rat cell lines.
    Ames RS, North SM, Fry KD, Tainsky MA, Nicolson GL, Roth JA.
    Cancer Res; 1989 May 01; 49(9):2312-9. PubMed ID: 2650864
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of growth of human tumor xenografts in athymic mice treated with ricin toxin A chain-monoclonal antibody 791T/36 conjugates.
    Byers VS, Pimm MV, Scannon PJ, Pawluczyk I, Baldwin RW.
    Cancer Res; 1987 Oct 01; 47(19):5042-6. PubMed ID: 3497715
    [Abstract] [Full Text] [Related]

  • 6. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
    Ramakrishnan S, Houston LL.
    Cancer Res; 1984 Apr 01; 44(4):1398-404. PubMed ID: 6142765
    [Abstract] [Full Text] [Related]

  • 7. Efficient transplantation of human non-T-leukemia cells into nude mice and induction of complete regression of the transplanted distinct tumors by ricin A-chain conjugates of monoclonal antibodies SN5 and SN6.
    Hara H, Luo Y, Haruta Y, Seon BK.
    Cancer Res; 1988 Aug 15; 48(16):4673-80. PubMed ID: 2969282
    [Abstract] [Full Text] [Related]

  • 8. Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer.
    Byers VS, Rodvien R, Grant K, Durrant LG, Hudson KH, Baldwin RW, Scannon PJ.
    Cancer Res; 1989 Nov 01; 49(21):6153-60. PubMed ID: 2790828
    [Abstract] [Full Text] [Related]

  • 9. Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in mice.
    Engert A, Martin G, Pfreundschuh M, Amlot P, Hsu SM, Diehl V, Thorpe P.
    Cancer Res; 1990 May 15; 50(10):2929-35. PubMed ID: 1692251
    [Abstract] [Full Text] [Related]

  • 10. Parameters affecting tumor-specific delivery of anti-CD5 antibody-ricin A chain immunotoxins in vivo.
    Rostaing-Capaillon O, Casellas P.
    Cancer Res; 1990 May 15; 50(10):2909-16. PubMed ID: 1692250
    [Abstract] [Full Text] [Related]

  • 11. A novel approach to production of antitumor monoclonal antibodies: antibody to a cell surface glycoprotein associated with transformation by a human oncogene.
    Roth JA, Scuderi P, Westin E, Gallo RC.
    Surgery; 1984 Aug 15; 96(2):264-72. PubMed ID: 6379959
    [Abstract] [Full Text] [Related]

  • 12. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy.
    Mulé JJ, Ettinghausen SE, Spiess PJ, Shu S, Rosenberg SA.
    Cancer Res; 1986 Feb 15; 46(2):676-83. PubMed ID: 3484431
    [Abstract] [Full Text] [Related]

  • 13. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
    Tong AW, Lee J, Stone MJ.
    Cancer Res; 1984 Nov 15; 44(11):4987-92. PubMed ID: 6207911
    [Abstract] [Full Text] [Related]

  • 14. Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies.
    Manzke O, Russello O, Leenen C, Diehl V, Bohlen H, Berthold F.
    Med Pediatr Oncol; 2001 Jan 15; 36(1):185-9. PubMed ID: 11464879
    [Abstract] [Full Text] [Related]

  • 15. Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody.
    Kawata A, Yoshida M, Okazaki M, Yokota S, Barcos M, Seon BK.
    Cancer Res; 1994 May 15; 54(10):2688-94. PubMed ID: 8168098
    [Abstract] [Full Text] [Related]

  • 16. Monoclonal antibody 45-2D9 recognizes a cell surface glycoprotein on a human c-Ha-ras transformed cell line (45-342) and a shared epitope on human tumors.
    Roth JA, Ames RS, Restrepo C, Scuderi P.
    J Immunol; 1986 Oct 01; 137(7):2385-9. PubMed ID: 3531330
    [Abstract] [Full Text] [Related]

  • 17. Comparison of growth inhibition of a human ovarian adenocarcinoma cell line by free monoclonal antibodies and their corresponding antibody-recombinant ricin A chain immunotoxins.
    Ettenson D, Sheldon K, Marks A, Houston LL, Baumal R.
    Anticancer Res; 1988 Oct 01; 8(4):833-8. PubMed ID: 3263079
    [Abstract] [Full Text] [Related]

  • 18. Effects of concomitant and sinecomitant immunity on postsurgical metastasis in mice.
    Nomi S, Naito K, Kahan BD, Pellis NR.
    Cancer Res; 1986 Dec 01; 46(12 Pt 1):6111-5. PubMed ID: 3779631
    [Abstract] [Full Text] [Related]

  • 19. Cytotoxic effect of anti-Mr 67,000 protein immunotoxins on human tumors in a nude mouse model.
    Weil-Hillman G, Runge W, Jansen FK, Vallera DA.
    Cancer Res; 1985 Mar 01; 45(3):1328-36. PubMed ID: 3971376
    [Abstract] [Full Text] [Related]

  • 20. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
    Xu F, Leadon SA, Yu Y, Boyer CM, O'Briant K, Ward K, McWatters A, Zhao X, Bae DS, DeSombre K, Zalutsky MR, Bast RC.
    Clin Cancer Res; 2000 Aug 01; 6(8):3334-41. PubMed ID: 10955821
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.